Quinoline compounds, preparation methods thereof, and uses thereof as urate transporter inhibitor drug
US10450274B2 · kind B2 · utility
0Cited by
2References
13Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 6, 2016 |
| Grant date | Oct 22, 2019 |
| Priority date | — |
| Expiry date | Dec 6, 2036 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D401/12
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Quinoline compounds and salts, hydrates or solvates serving as a selective uric acid reabsorption inhibitor, can be used in the treatment of hyperuricemia and gout by promoting uric acid to excrete from the body and reducing serum uric acid. Such compounds have the effect of reducing the uric acid in the animal body and human body.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.